ClinicalTrials.Veeva

Menu

Study of Acid Peel and Laser for the Treatment of Melasma

Northwestern University logo

Northwestern University

Status

Completed

Conditions

Melasma

Treatments

Procedure: Laser Treatment
Procedure: Acid Peel

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.

Full description

The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.

Enrollment

15 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of melasma lesion measuring at least 4 square centimeters.
  • Age 18-75 years.
  • Good health.
  • Willingness and ability to understand and provide informed consent for participation in the study.
  • Ability to communicate with the investigator.
  • Must be willing to forgo other treatment options for melasma during the course of the study.

Exclusion criteria

  • Inability to understand the protocol or to give informed consent.
  • Mental illness.
  • Under 18 years of age and over 75 years of age.
  • Laser treatment in the last 6 months before enrollment.
  • Isotretinoin within the past year.
  • Lidocaine allergy.
  • History of herpes simplex viral infection.
  • Concurrent active disease to facial area (i.e acne).
  • Bleeding disorder.
  • History of abnormal wound healing.
  • History of abnormal scarring.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

15 participants in 2 patient groups

1
Experimental group
Description:
Laser Treatment
Treatment:
Procedure: Laser Treatment
2
Experimental group
Description:
Acid peel
Treatment:
Procedure: Acid Peel

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems